Showing results (61-70 of 114) with videos related to

Sort By:
Pageof 12
Neurology|July 2, 2021
Diabetes Mellitus and Cognition: Pathway Analysis in the MEMENTO CohortEric Frison, Cecile Proust-Lima, Jean-Francois Mangin, et al.
European Journal of Human Genetics : EJHG|April 2, 2015
Mutation in the 3'untranslated region of APP as a genetic determinant of cerebral amyloid angiopathyGaël Nicolas, David Wallon, Claudia Goupil, et al.
Alzheimer'S Research & Therapy|December 6, 2014
A diagnostic scale for Alzheimer's disease based on cerebrospinal fluid biomarker profilesSylvain Lehmann, Julien Dumurgier, Susanna Schraen, et al.
BMJ Open|June 2, 2019
What is the clinical impact of cerebrospinal fluid biomarkers on final diagnosis and management in patients with mild cognitive impairment in clinical practice? Results from a nation-wide prospective survey in FranceEmmanuel Cognat, François Mouton Liger, Anne-Cécile Troussière, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 16, 2020
Clinical relevance of brain atrophy subtypes categorization in memory clinicsVincent Planche, Vincent Bouteloup, Jean-François Mangin, et al.
Journal of Neurology|June 28, 2020
High diagnostic value of plasma Niemann-Pick type C biomarkers in adults with selected neurological and/or psychiatric disordersDaniele Mandia, Marion Plaze, Isabelle Le Ber, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|August 17, 2018
Somatic variants in autosomal dominant genes are a rare cause of sporadic Alzheimer's diseaseGaël Nicolas, Rocío Acuña-Hidalgo, Michael J Keogh, et al.
Acta Neuropathologica|June 7, 2021
Clinical and neuropathological diversity of tauopathy in MAPT duplication carriersDavid Wallon, Susana Boluda, Anne Rovelet-Lecrux, et al.
BMJ Open|June 27, 2019
How many patients are eligible for disease-modifying treatment in Alzheimer's disease? A French national observational study over 5 yearsStéphane Epelbaum, Claire Paquet, Jacques Hugon, et al.
The Journal of Prevention of Alzheimer'S Disease|January 12, 2025
Usefulness of Cerebrospinal Fluid Alzheimer's disease biomarkers in older patients: Evidence from a national multicenter prospective studyThéodore Decaix, François Mouton-Liger, Julien Dumurgier, et al.
Pageof 12